4D Molecular Therapeutics, Inc. (FDMT)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 26.76 |
| Open | 26.79 |
| Bid | 26.75 x 100 |
| Ask | 26.85 x 200 |
| Day's range | 26.26 - 27.09 |
| 52-week range | 9.44 - 36.25 |
| Volume | |
| Avg. volume | 713,801 |
| Market cap | 1.371B |
| Beta (5Y monthly) | 2.86 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
4D Molecular Therapeutics, Inc. (FDMT) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
4D Molecular Therapeutics (FDMT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- GuruFocus.com
4D Molecular Therapeutics Inc (FDMT) Chief Legal Officer Scott Bizily Sells 8,153 Shares
On April 1, 2024, Chief Legal Officer Scott Bizily sold 8,153 shares of 4D Molecular Therapeutics Inc (NASDAQ:FDMT) according to a recent SEC Filing.
- GuruFocus.com
4D Molecular Therapeutics Inc's Chief Legal Officer Sells Company Shares
Scott Bizily, the Chief Legal Officer of 4D Molecular Therapeutics Inc (NASDAQ:FDMT), has sold 5,833 shares of the company on March 27, 2024, according to a recent SEC filing.
© 2024 Yahoo. All rights reserved.